NCT02215044 Dose-finding Study of BI 2536 Administered in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT02215031 Safety, Tolerability and Pharmacokinetics of Single Rising Intravenous Doses of BI 44370 BS Solution in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02215018 Safety, Tolerability and Pharmacokinetics of BI 44370 TA Oral Drinking Solution in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02215005 Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02214992 Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02214979 Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02214966 Influence of Food on the Bioavailability of Telmisartan / Ramipril Fixed Dose Combination in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02214953 Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02214940 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple, Rising Oral Doses of BI 11634 Oral Solution in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02214927 Pharmacokinetics and Relative Bioavailability of 11634 Immediate Release Tablet in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02214914 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 11634 Solution in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02214901 Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02214888 Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT02212938 Influence of a Standardised High Fat Breakfast on the Bioavailability of BI 14332 CL in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02212925 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes Status TERMINATED Phase PHASE1
NCT02211989 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 14332 CL Powder in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02211976 Efficacy and Tolerability of Bisacodyl Sugar Coated Tablets, Simeticone Chewing Tablets and Their Combination in Constipation and Bloatedness Status COMPLETED Phase PHASE3
NCT02211963 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT02211950 Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02211937 Relative Oral Bioavailability of BI 44847 as Suspension Compared to Tablet and the Influence of Food Anf of BI 44847 as Solution Compared to Tablet in Healthy Male Volunteers Status COMPLETED Phase PHASE1